EOFlow Co. Ltd.
2023
$738M
Outcome
Strategic integration
Medtronic
Medical Technology- HQ today: Minneapolis, Minnesota, United States
Reviewed by Swet Parvadiya
Company data updated: November 2026
Acquisitions
Medtronic Acquisitions
4
Major Deals Covered
$53.3B
Disclosed Deal Value
What are Medtronic's biggest acquisitions?
Medtronic's largest disclosed acquisition here is EOFlow Co. Ltd. for $738 in 2023. This page covers 4 major deals from 2015 to 2023, each with its price where disclosed and the reason behind it.
- Major deals covered
- 4
- Largest deal
- EOFlow Co. Ltd. ($738)
- First deal
- 2015
- Most recent
- 2023
| Company | Year | Price | Purpose |
|---|---|---|---|
| Covidien plc | 2015 | Undisclosed | — |
| Mazor Robotics | 2018 | Undisclosed | — |
| Intersect ENT | 2022 | Undisclosed | — |
| EOFlow Co. Ltd. | 2023 | Undisclosed | — |
- What companies has Medtronic bought?
- Major acquisitions by Medtronic documented here include EOFlow Co. Ltd. (2023), Covidien plc (2015), Mazor Robotics (2018) and Intersect ENT (2022).
- What is Medtronic's most recent acquisition?
- The most recent Medtronic acquisition documented here is EOFlow Co. Ltd., in 2023, for $738.
Intersect ENT
2022
$1.1B
Outcome
Integrated
Mazor Robotics
2018
$1.6B
Outcome
Integrated
Covidien plc
2015
$49.9B
Outcome
Fully integrated
Medtronic's Growth & Acquisition Strategy
Medtronic’s growth strategy centers on expanding surgical robotics adoption, scaling leadless cardiac devices, integrating AI-driven health ecosystems, and accelerating penetration in emerging international markets.
How Medtronic Makes Money
Medtronic operates a diversified global medical technology business model, generating revenue through four primary operating segments: Cardiovascular, Medical Surgical, Neuroscience, and Diabetes. It monetizes through the sale of proprietary implantable devices, surgical instruments, capital equipment (such as robotic systems), and consumable accessories to hospitals, clinics, and healthcare institutions across 150+ countries.
Medtronic Acquisitions FAQ
What is Medtronic's general approach to M&A and acquisitions?
Medtronic pursues a disciplined, strategic M&A approach focused on acquiring proprietary technologies, expanding customer distribution reach, and unlocking operational cost synergies rather than pursuing unselective scale.
What were some of the most transformative acquisitions completed by Medtronic?
Transformative transactions in Medtronic's history include pivotal mergers and acquisitions that secured key regional footprints, consolidated core market share, and brought proprietary software intellectual property in-house.
How does Medtronic successfully integrate acquired companies?
Medtronic deploys dedicated integration teams to harmonize core software stacks, align regulatory compliance systems, and unite company cultures while preserving entrepreneurial agility.
Does Medtronic divest non-core corporate assets?
Yes, Medtronic periodically evaluates its corporate portfolio, strategically divesting non-core or non-strategic assets to redeploy capital into high-margin core operational divisions.
Related Companies
Compare Medtronic With Competitors
Related M&A Histories
Compare corporate acquisition records, deal values, and strategic targets
Explore Medtronic
Core profile pages, founders and related research hubs for this company.